| Requirement |
1 | Men with metastatic prostate ca about to begin a systemic therapy involving androgen-deprivation therapy or docetaxel |
2 | At least 18 years of age |
3 | No signs or symptoms of active infection |
4 | Willing to comply with experimental procedures |
5 | Signed an approved study-specific informed consent and HIPAA |